We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Innovation Fund Boosts Commercialization of Purdue Technologies

News   Jan 31, 2013

 
Innovation Fund Boosts Commercialization of Purdue Technologies
 
 
Advertisement
 

RELATED ARTICLES

Two Immunotherapies Converted Into Single Therapy for Certain Blood Cancers

News

Scientists have combined two immunotherapy strategies into a single therapy. In studies using human cells and in mice, the novel therapy was more effective than either alone in treating certain blood cancers.

READ MORE

“Self-Eating” Stem Cells May Hold the Key to New Regenerative Therapies

News

The self-eating process in embryonic stem cells and a related metabolite may serve as promising new therapeutic targets to repair damaged cells and organs, researchers say.

READ MORE

Refining Adoptive Cell Therapy for Advanced Cancers

News

Adoptive cell transfer immunotherapy is a promising new treatment for people with hard-to-treat cancers. However, the process is complex and requires fine-tuning to enable it to work for more people.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE